Landmark Federal Lawsuit Challenges Legality of the GLOBE Pricing Model
The Pharmaceutical Research and Manufacturers of America (PhRMA), representing the nation's leading biopharmaceutical companies, filed a major federal lawsuit on Wednesday challenging the Trump administration's attempt to index domestic hospital drug prices to international benchmarks under Medicare Part B.
The complaint, filed in the US District Court for the District of Columbia, directly names Health Secretary Robert F. Kennedy Jr., the Department of Health and Human Services (HHS), the Centers for Medicare & Medicaid Services (CMS) led by Administrator Dr.















